Navigation Links
Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
Date:9/26/2007

the hugely successful campaign last year. Our commitment for a second year underscores our backing for Camfed's work and goals - and it mirrors the long- term commitment the charity makes to the girls it supports. The generosity of our readers has already ensured that CAMFED can support more than 2,000 girls through to the end of their secondary education. We aim to add greatly to that number this year."

More information on the Financial Times Seasonal Appeal and CAMFED International can be found at http://www.ft.com/appeal

For further information please contact:

Jo Crosby Darcy Keller

Communications Manager Communications Executive

Financial Times (UK) Financial Times (US)

T: +44 (0) 20 7873 3811 T: 212 641 6614

E: jo.cosby@ft.com E: darcy.keller@ft.com

Ann Cotton Brooke Hutchinson

Executive Director Executive Director CAMFED USA

CAMFED International CAMFED USA

T: +44 (0) 1223 227038 T: +01 (415) 979 1556

M: +44 (0) 7921 049576 M: +01 (650) 892 7034

E: acotton@camfed.org E: bhutchinson@camfed.org

About the Financial Times:

The Financial Times Group, one of the world's leading business information companies, aims to provide a broad range of business information and services to the growing audience of internationally minded business people. The FT Group includes:

1. The Financial Times, one of the world's leading business newspapers, is

recognised internationally for its authority, integrity and accuracy.

Providing extensive news, comment and analysis, the newspaper is

printed
'/>"/>

SOURCE The Financial Times
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
2. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
3. Health conditions and patient treatment affected by a financial crunch
4. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
5. Bird Flu: Fear of the Unknown Could Put Financial Markets in a Soup
6. Huge financial losses due to Bird flu scare!
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Elective Surgery - the Financial Whipping Boy
9. British Hospitals Face Financial Crisis
10. Kidney donors do not realize financial gains
11. Bird-Flu Pandemic will be a Huge Financial Drain, says World Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created ...l companies reported a different kind of slowdown:...us months. , Seattle, WA ... created in the medical field slowed in June overa...kind of slowdown that will be music to the ears of...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begins -...-- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a l... today that its subsidiary has commenced commercia...les USP product in the 40mg,strength from its Davi...with the launch, Watson has 180 days of marketing ...
(Date:7/25/2008)...BURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmac...eutical company, today announced that it,has launc...iarrhythmic,indicated for the treatment and prophy...tion and hemodynamically unstable ventricular,tach...r heart beat.,Sagent,s amiodarone HCl injection wi...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...have found that twins are performing on par with o...e. Previously the performance of the twins// has b...other average students. Researchers felt this was ...rom parents as well as have low educational motiva...
...s: Suicide rates among younger and older Americans...he puzzling news: No one really knows why// . Tho...chers at the University of South Carolina and rele... the October issue of the American Journal of Publ...
... by scientists at the Broad Institute of MIT and H...nd of genetic “roadmap” that can connect human dis...l as predict how new drugs work in human cells. Ca... uses are described in the September 29 issue of S...
...ns faculty members performing microsurgery in Tanz...ting room, or health care experts// in Vietnam pre...ents gathered in the Hopkins outpatient center. Th...gh-tech Internet communication system that will be...
Other Medicine News:Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
(Date:7/24/2008)...Circulating Tumor Cells, RARITAN, N.J., July 25 /...cal trial found the number of circulating tumor ce...ee and overall survival among metastatic,colorecta... in the July 1,issue of the Journal of Clinical On...erlands, and the United,Kingdom, found that metast...
(Date:7/24/2008)...SNewswire/ -- Headlines claiming "soy,products low...mall scale,preliminary study that Dr. Jorge Chava...sed on recollected intake of soyfoods and not on,s...confounded by many,issues, thus I feel the results...arned Dr. Tammy Hedlund, a researcher in prostate ...
(Date:7/23/2008)...mic Therapy to Treat the Disease -, WAYNE, N.J. a...ll/ --,Bayer HealthCare Pharmaceuticals and Onyx P...d that The New England Journal of Medicine publish...exavar(R) (sorafenib),tablets decreased the absolu...resectable hepatocellular carcinoma (HCC), or live...
(Date:7/23/2008)...e Body Have Greater Concentrations of,Stem Cells, ...wswire/ -- Fat removed,from the lower abdomen and ... excellent source of stem cells, with higher stem ...reports a Brazilian-based study in August,s,Plasti...cal journal of the,American Society of Plastic Sur...
Breaking Medicine Technology:Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 2Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 3Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 1Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 2Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 3Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 4Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 5Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 6New transfusion rules restrict donations from previously pregnant women 2632 1New transfusion rules restrict donations from previously pregnant women 2632 2New transfusion rules restrict donations from previously pregnant women 2632 3AGD Applauds Congressional Support of SCHIP Reauthorization 2630 1AGD Applauds Congressional Support of SCHIP Reauthorization 2630 2Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 1Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 2Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 3
...DGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Resu...trolled, open-label, Phase,3 study showed that 77 ...ults taking PREZISTA(TM) (darunavir) 600 mg tablet...plus an optimized,background regimen (OBR) of anti...ad of <400 copies/mL at week 48, compared to 68,pe...
...rst prospective biomarker trial in non-small cell ...ire-FirstCall/ -- Response,Genetics, Inc. today an...ished in the July 1 issue of the Journal of Clinic...omarker,Excision-Repair Cross-Complementing 1 (ERC...ell lung cancer (NSCLC) predicts for,sensitivity t...
Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
The Libert Coronary Stent System introduces a new generation of lesion access and conformability. With exceptional flexibility, a low crossing profile, and the leading delivery catheter, the performa
..., and microplatesthat is the area of research in w...increasing force. Ergonomics (reduced weight and e...nel Research model was developed. This high-perfor... precise, and rapid processing of long series for ...
The Finnpipette Digital Multichannel, with it's streamlined design, makes even lighter work of routine laboratory tasks. The multichannel offers all these advanced features: Soft-touch tip ejection,
...mics, and value!, Comfortable feel and less hand ...er control while pipetting with smooth, light plun...long, lever tip ejector , Completely autoclavable ... the need for recalibration , Easy-to-read precisi...
Medicine Products: